Mariamena Arbitrio

2.4k total citations
62 papers, 1.4k citations indexed

About

Mariamena Arbitrio is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Mariamena Arbitrio has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 24 papers in Oncology and 13 papers in Hematology. Recurrent topics in Mariamena Arbitrio's work include Multiple Myeloma Research and Treatments (12 papers), Gene expression and cancer classification (9 papers) and MicroRNA in disease regulation (7 papers). Mariamena Arbitrio is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Gene expression and cancer classification (9 papers) and MicroRNA in disease regulation (7 papers). Mariamena Arbitrio collaborates with scholars based in Italy, United States and France. Mariamena Arbitrio's co-authors include Pierfrancesco Tassone, Maria Teresa Di Martino, Francesca Scionti, Daniele Caracciolo, Pierosandro Tagliaferri, Pierosandro Tagliaferri, Pietro Hiram Guzzi, Giuseppe Agapito, Mario Cannataro and Cirino Botta and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Mariamena Arbitrio

62 papers receiving 1.4k citations

Peers

Mariamena Arbitrio
Biyin Cao China
Wenan Qiang United States
Peter P. Sayeski United States
Jia Xu China
Wooyoung Hur United States
Allan S. Wagman United States
Biyin Cao China
Mariamena Arbitrio
Citations per year, relative to Mariamena Arbitrio Mariamena Arbitrio (= 1×) peers Biyin Cao

Countries citing papers authored by Mariamena Arbitrio

Since Specialization
Citations

This map shows the geographic impact of Mariamena Arbitrio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariamena Arbitrio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariamena Arbitrio more than expected).

Fields of papers citing papers by Mariamena Arbitrio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariamena Arbitrio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariamena Arbitrio. The network helps show where Mariamena Arbitrio may publish in the future.

Co-authorship network of co-authors of Mariamena Arbitrio

This figure shows the co-authorship network connecting the top 25 collaborators of Mariamena Arbitrio. A scholar is included among the top collaborators of Mariamena Arbitrio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariamena Arbitrio. Mariamena Arbitrio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arbitrio, Mariamena, Marianna Milano, Maria Lucibello, et al.. (2025). Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis. Frontiers in Pharmacology. 16. 1548991–1548991. 1 indexed citations
2.
Cioce, Mario, Mariamena Arbitrio, Nicoletta Polerà, et al.. (2024). Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity. Cancer Drug Resistance. 7. 45–45. 1 indexed citations
3.
Agapito, Giuseppe, Marianna Milano, Francesca Scionti, et al.. (2024). Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity. 4331–4337. 1 indexed citations
4.
Staropoli, Nicoletta, Domenico Ciliberto, Francesco Luciano, et al.. (2023). The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis. Critical Reviews in Oncology/Hematology. 193. 104229–104229. 4 indexed citations
5.
Polerà, Nicoletta, Antonia Mancuso, Caterina Riillo, et al.. (2023). The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas. Cancers. 15(6). 1647–1647. 1 indexed citations
6.
Scionti, Francesca, Giada Juli, Roberta Rocca, et al.. (2023). TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma. Journal of Experimental & Clinical Cancer Research. 42(1). 71–71. 14 indexed citations
7.
Grillone, Katia, Caterina Riillo, Roberta Rocca, et al.. (2022). The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma. International Journal of Molecular Sciences. 23(18). 10222–10222. 32 indexed citations
8.
Scionti, Francesca, Mariamena Arbitrio, Daniele Caracciolo, et al.. (2021). Integration of DNA Microarray with Clinical and Genomic Data. Methods in molecular biology. 2401. 239–248. 5 indexed citations
9.
Agapito, Giuseppe & Mariamena Arbitrio. (2021). Microarray Data Analysis Protocol. Methods in molecular biology. 2401. 263–271. 7 indexed citations
10.
Greco, Alessandro, Mariamena Arbitrio, Pierosandro Tagliaferri, et al.. (2020). Development and validation of bioanalytical methods for LNA-i-miR-221 quantification in human plasma and urine by LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 188. 113451–113451. 6 indexed citations
11.
Martino, Maria Teresa Di, Mariamena Arbitrio, Daniele Caracciolo, et al.. (2020). Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats. Molecular Therapy — Nucleic Acids. 20. 73–85. 12 indexed citations
12.
Caracciolo, Daniele, Francesca Scionti, Giada Juli, et al.. (2020). Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma. Haematologica. 106(1). 185–195. 34 indexed citations
13.
Cantafio, Maria Eugenia Gallo, Maria Anna Siciliano, Caterina Riillo, et al.. (2019). Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. Journal of Hematology & Oncology. 12(1). 32–32. 33 indexed citations
14.
Scionti, Francesca, Maria Teresa Di Martino, Simona Sestito, et al.. (2017). Genetic variants associated with Fabry disease progression despite enzyme replacement therapy. Oncotarget. 8(64). 107558–107564. 28 indexed citations
15.
Rossi, Marco, Emanuela Altomare, Nicola Amodio, et al.. (2017). Th17 Cells Targeting By MiR-21 Inhibitor Impairs Multiple Myeloma Related Bone Disease. Blood. 130. 4380–4380. 2 indexed citations
16.
Guzzi, Pietro Hiram, Giuseppe Agapito, Maria Teresa Di Martino, et al.. (2012). DMET-Analyzer: automatic analysis of Affymetrix DMET Data. BMC Bioinformatics. 13(1). 258–258. 52 indexed citations
17.
Neri, Paola, Pierosandro Tagliaferri, Maria Teresa Di Martino, et al.. (2008). In vivo anti‐myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor. British Journal of Haematology. 143(4). 520–531. 56 indexed citations
18.
Nisticó, Giuseppe, Maria Cristina Caroleo, Mariamena Arbitrio, & Luigi Pulvirenti. (1994). Corticotropin-Releasing Factor Microinfused into the Locus coeruleus Produces Electrocortical Desynchronization and Immunosuppression. NeuroImmunoModulation. 1(2). 135–140. 8 indexed citations
19.
Nisticò, Giuseppe, Maria Cristina Caroleo, Mariamena Arbitrio, & Luigi Pulvirenti. (1994). Evidence for an Involvement of Dopamine D<sub>1</sub> Receptors in the Limbic System in the Control of Immune Mechanisms. NeuroImmunoModulation. 1(3). 174–180. 22 indexed citations
20.
Caroleo, Maria Cristina, Mariamena Arbitrio, Daniela Melchiorri, & Giuseppe Nisticó. (1994). A Reappraisal of the Role of the Various Opioid Receptor Subtypes in Cell-Mediated Immunity. NeuroImmunoModulation. 1(2). 141–147. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026